natgillin/translations-raw huggingface dataset:
Repatha var i begge doser effektiv i alle undergrupper sammenlignet med placebo og ezetimibe, uden at der blev observeret nogen mærkbare forskelle mellem undergrupper, for eksempel alder, race, køn, region, body mass index, National Cholesterol Education Program-risiko, aktuelle rygerstatus, risikofaktorer for koronar hjertesygdom (CHD) ved baseline, familiære tilfælde af præmatur CHD, glucosetolerancestatus (dvs. diabetes mellitus type 2, metabolisk syndrom eller begge), hypertension, statindosis og -styrke, ubundet PCSK-9 ved baseline, LDL-C ved baseline og TG ved baseline.
Repatha at either dose was effective in all subgroups relative to placebo and ezetimibe, with no notable differences observed between subgroups, such as age, race, gender, region, body-mass index, National Cholesterol Education Program risk, current smoking status, baseline coronary heart disease (CHD) risk factors, family history of premature CHD, glucose tolerance status, (i.e., diabetes mellitus type 2, metabolic syndrome, or neither), hypertension, statin dose and intensity, unbound baseline PCSK9, baseline LDL-C and baseline TG.
Repatha viste bedre effekt end ezetimibe på reduktion af LDL-C, TC, ApoB, non-HDL-C, Lp(a), TC/HDL-C og ApoB/ApoA1.
Repatha was superior to ezetimibe in reducing LDL-C, TC, ApoB, non-HDL-C, Lp(a), TC/HDL-C, and ApoB/ApoA1.
REPLACE-2-studieresultater: 30-dages endepunkt (intent-to-treat- og per-protokol- population)
REPLACE-2 study results: 30-day endpoints (intent-to-treat and per-protocol populations
Replagal 1 mg/ml koncentrat til infusionsvæske, opløsning
Replagal 1 mg/ml concentrate for solution for infusion
Replagal 1 mg/ml koncentrat til infusionsvæske, opløsning Agalsidase alfa
Replagal 1 mg/ml concentrate for solution for infusion agalsidase alfa
Replagal 1 mg/ml koncentrat til infusionsvæske, opløsning.
Replagal 1 mg/ml concentrate for solution for infusion.
Replagal 1 mg/ml koncentrat, sterilt Agalsidase alfa
Replagal 1 mg/ml sterile concentrate agalsidase alfa
Replagal blev også associeret med forbedret myokardiel kontraktion, en reduktion i den gennemsnitlige QRS- varighed og en samtidig reduktion i septumtykkelse målt ved ekkokardiografi.
Replagal was also associated with improved myocardial contractility, a decrease in mean QRS duration and a concomitant decrease in septal thickness on echocardiography.
Replagal blev oprindeligt godkendt under "særlige omstændigheder", da der på godkendelsestidspunktet kun forelå sparsomme oplysninger som følge af sygdommens sjældenhed.
Replagal was originally authorised under ‘exceptional circumstances’, because as the disease is rare, limited information was available at the time of approval.
Replagal indgives i en dosis på 0,2 mg/kg legemsvægt hver anden uge som en intravenøs infusion over 40 minutter.
Replagal is administered at a dose of 0.2 mg/kg body weight every other week by intravenous infusion over 40 minutes.
Replagal må ikke infunderes samtidig med andre lægemidler i samme slange.
Do not infuse Replagal concomitantly in the same intravenous line with other agents.
Replagal reducerede den venstre ventrikelmasse med gennemsnitlig 11,5 g, mens patienter, som modtog placebo, oplevede en stigning i venstre ventrikelmasse på 21,8 g.
Replagal reduced left ventricle mass by an average of 11.5 g while patients receiving placebo had an increase in left ventricular mass of 21.8 g.
Replikationsmekanismen bliver stoppet hovedsagelig i celler, der er inficeret med virus, både ved ødelæggelse af mRNA og inaktivering af translationsproteiner (2’5’ oligo-adenylat syntetaseaktivering).
It is mainly in cells infected by virus that the mechanism of replication is stopped both by destruction of mRNA and by inactivation of translation proteins (2'5' oligo-adenylate synthetase activation).
Replikoner, der indeholder NS5B fra kliniske isolater
Replicons containing NS5B from clinical isolates
Replikoner- genotype
Genotype replicons
Replikongenotype
Replicon genotype
Reproduction is authorised provided the source is acknowledged
Reproduction is authorised provided the source is acknowledged. dummy treatment).
Reproduction is authorised provided the source is acknowledged blokerer et enzym kaldet catechol-O-methyltransferase (COMT), som er med til at nedbryde levodopa i kroppen.
Reproduction is authorised provided the source is acknowledged. catechol-O-methyl transferase (COMT).
Reproduction is authorised provided the source is acknowledged kulhydratstofskiftet.
Reproduction is authorised provided the source is acknowledged. carbohydrates.
Reproduction is authorised provided the source is acknowledged primære effektmål var vægtforøgelsesraten hos de vaccinerede grise, men i undersøgelserne kiggede man også på andre parametre, herunder symptomer, PCV2-niveauet i blodet og antallet af vraggrise.
The main measure of effectiveness was the rate of weight gain in the vaccinated pigs, but the studies also looked at other parameters including symptoms, the level of PCV2 in the blood and the number of runts.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. after the end of the operation.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. been inactivated so that it cannot cause the disease.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. day.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. ensure that they are above set minimum levels.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. five minutes on days 1 and 8 of each cycle.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. for a further four doses.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. permanently stopped.
Reproduction is authorised provided the source is acknowledged. af clostridia, bakterier, der producerer et toksin, som lammer tarmen.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. af slimhinden i livmoderen.
Reproduction is authorised provided the source is acknowledged. controlling the growth of the lining of the womb.
Reproduction is authorised provided the source is acknowledged. afgørende betydning, bør disse patienter højst få én dosis Ablavar under hver MRI-scanning, og der skal være et interval på mindst en uge mellem hver Ablavar-injektion.
Reproduction is authorised provided the source is acknowledged. more than one dose during each MRI scan, and there should be a gap of at least a week between each Ablavar injection.
Reproduction is authorised provided the source is acknowledged. alder og helbred.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. alfa, virker på samme måde i kroppen som kroppens egen faktor XIII, men har en lidt forskellig opbygning.
Reproduction is authorised provided the source is acknowledged. susoctocog alfa, works in the body in the same way as human factor VIII, but has a slightly different shape.
Reproduction is authorised provided the source is acknowledged. allergiske symptomer.
Reproduction is authorised provided the source is acknowledged. attaches itself.
Reproduction is authorised provided the source is acknowledged. almindeligt vand (i områder med hårdt vand, hvor postevandet indeholder en del opløst calcium, kan flaskevand med lavt mineralindhold anvendes).
Reproduction is authorised provided the source is acknowledged. where tap water contains a lot of dissolved calcium, bottled water with a low mineral content may be used).
Reproduction is authorised provided the source is acknowledged. almindeligvis med en initialdosis på fire 75 mg -tabletter.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. anden dosis, og mindst tre måneder mellem den anden og den tredje dosis, og alle doserne bør gives i løbet af et år.
Reproduction is authorised provided the source is acknowledged. the second doses, and at least three months between the second and the third, and all doses should be given within a year.
Reproduction is authorised provided the source is acknowledged. antibiotikabehandling.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. anvendes af én person.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. anvendes til patienten, baseres på den mængde levodopa, der er nødvendig til kontrol af patientens symptomer.
Reproduction is authorised provided the source is acknowledged. patient should use is based on the amount of levodopa they need to control their symptoms.
Reproduction is authorised provided the source is acknowledged. at blokere nedbrydningen af dem i blodet og stimulerer dermed bugspytkirtlen til at producere mere insulin, når blodsukkerniveauet er højt.
Reproduction is authorised provided the source is acknowledged. glucose levels are high.
Reproduction is authorised provided the source is acknowledged. at fremkalde sygdom).
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. at trænge ind i celler fra blodet.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. at vaccinen kan bevare sin effekt.
Reproduction is authorised provided the source is acknowledged. the vaccine’s effect.
Reproduction is authorised provided the source is acknowledged. aureus (MRSA)).
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. behandlingen fortsætte i flere måneder for at undgå, at sygdommen vender tilbage, eller længere hos patienter, der tidligere gentagne gange har haft perioder med depression.
Reproduction is authorised provided the source is acknowledged. continue for several months to prevent the disease coming back, or for longer in patients who have had repeated periods of depression in the past.
Reproduction is authorised provided the source is acknowledged. behandlingen, og, hvis det drejer sig om børn, af kroppens overfladeareal.
Reproduction is authorised provided the source is acknowledged. the patient responds to treatment and, in the case of children, on the body surface area.
Reproduction is authorised provided the source is acknowledged. behandlingen.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. behandlingen.
Reproduction is authorised provided the source is acknowledged. due to side effects, especially during the first eight weeks of therapy.
Reproduction is authorised provided the source is acknowledged. beslægtet med andre bredt tilgængelige lægemidler til behandling af malaria.
Reproduction is authorised provided the source is acknowledged. bisquinolone.
Reproduction is authorised provided the source is acknowledged. bindes til T-cellerne blokerer daclizumab interleukin-2, hvorved T-cellerne forhindres i at angribe og beskadige nervecellerne.
Reproduction is authorised provided the source is acknowledged. attacking and damaging nerve cells.
Reproduction is authorised provided the source is acknowledged. bivirkninger kan det være nødvendigt at justere dosis.
Reproduction is authorised provided the source is acknowledged. need to be adjusted for patients who experience side effects.
Reproduction is authorised provided the source is acknowledged. bivirkninger.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. bivirkningerne bliver uacceptable.
Reproduction is authorised provided the source is acknowledged. worse or side effects become unacceptable.
Reproduction is authorised provided the source is acknowledged. bivirkningerne fortsætter ved en reduceret dosis på 20 mg/m2.
Reproduction is authorised provided the source is acknowledged. continue at a reduced dose of 20 mg/m2.
Reproduction is authorised provided the source is acknowledged. blande indholdet med en lille mængde syrlig mad, f.eks. frugtpuré, som så skal synkes med det samme uden at tygge.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. blodlegemers vækst og aktivitet.
Reproduction is authorised provided the source is acknowledged. stimulates the growth and activity of eosinophils.
Reproduction is authorised provided the source is acknowledged. blæredannende udslæt, som regel på den ene side af kroppen.
Reproduction is authorised provided the source is acknowledged. blistering rash typically in one part of the body.
Reproduction is authorised provided the source is acknowledged. bør behandlingen fortsættes i flere måneder for at forhindre tilbagefald eller endnu længere hos patienter, som tidligere har haft gentagne perioder med depression
Reproduction is authorised provided the source is acknowledged. months to prevent the disease coming back, or for longer in patients who have had repeated periods of depression in the past.
Reproduction is authorised provided the source is acknowledged. cyclooxygenase 2 (COX 2).
Reproduction is authorised provided the source is acknowledged. inflammation.
Reproduction is authorised provided the source is acknowledged. dage til behandling og kontrol af Trichuris suis.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. dagens første måltid eller drikkevarer indtages.
Reproduction is authorised provided the source is acknowledged. first food or drink of the day.
Reproduction is authorised provided the source is acknowledged. dagens første måltid, som skal indtages mindst 30 minutter efter tabletten.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. dagens første måltid, som skal indtages mindst 30 minutter efter tabletten.
Reproduction is authorised provided the source is acknowledged. the day, which should be at least 30 minutes after taking the tablet.
Reproduction is authorised provided the source is acknowledged. dem.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. der er blevet genetisk modificerede1.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. der er en variant, som er vanskeligere at behandle.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. deres indbyrdes kommunikation.
Reproduction is authorised provided the source is acknowledged. each other.
Reproduction is authorised provided the source is acknowledged. det således muligt for blodkarrene at udvide sig.
Reproduction is authorised provided the source is acknowledged. therefore allowing the blood vessels to widen.
Reproduction is authorised provided the source is acknowledged. dosis på 800 mg én gang dagligt til tidligere behandlede patienter, hvis de er tilstrækkeligt raske, og det er påvist, at den hivvirus, der forårsager deres infektion, ikke er resistent over for Prezista.
Reproduction is authorised provided the source is acknowledged. be taken by previously treated patients, provided that the patients are healthy enough and that the HIV virus causing their infection has been shown not to be resistant to Prezista.
Reproduction is authorised provided the source is acknowledged. dosis tåles godt.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. efterfølgende doser være på 5 mikrogram.
Reproduction is authorised provided the source is acknowledged. consecutive doses should be 5 micrograms.
Reproduction is authorised provided the source is acknowledged. efterfølgende udsættes for bluetongue-vira, vil immunsystemet hurtigere kunne danne antistoffer mod dem.
In the future, if the animals are exposed to the bluetongue virus, their immune systems will be able to produce antibodies more quickly.
Reproduction is authorised provided the source is acknowledged. efterfølgende udsættes for bluetongue-vira, vil immunsystemet hurtigere kunne danne antistoffer mod dem.
Reproduction is authorised provided the source is acknowledged. exposed to the bluetongue virus, the immune system will be able to produce antibodies more quickly.
Reproduction is authorised provided the source is acknowledged. eksisterende behandling med en betablokker-øjendråbe blev sammenlignet med effekten af at tilføje placebo (en uvirksom øjendråbe) i en undersøgelse, der omfattede 285 patienter.
Reproduction is authorised provided the source is acknowledged. study involving 285 patients.
Reproduction is authorised provided the source is acknowledged. eller helt stoppe behandlingen af patienter, som udviser symptomer på leverproblemer eller andre bivirkninger.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. eller mellemmåltid.
Reproduction is authorised provided the source is acknowledged. out shortly before or after a meal or snack.
Reproduction is authorised provided the source is acknowledged. eller Prograft, som fås i kapsler.
Reproduction is authorised provided the source is acknowledged. is available as capsules.
Reproduction is authorised provided the source is acknowledged. en gang dagligt i mindst 4 uger (ved myokardieinfarkt med forhøjelse af ST-segmentet) eller i op til 12 måneder (ved syndrom uden ST-segmentforhøjelse).
Reproduction is authorised provided the source is acknowledged. a day for at least four weeks (in ST segment elevation myocardial infarction) or for up to 12 months (in non-ST segment elevation syndrome).
Reproduction is authorised provided the source is acknowledged. end det normale niveau).
Reproduction is authorised provided the source is acknowledged. than three times the normal level).
Reproduction is authorised provided the source is acknowledged. er blevet påført, fortæres de af insekterne (indoxacarb omdannes i insekternes tarm til den aktive form).
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. for den enkelte patient op til ny vurdering efter to års behandling.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. for oral suspension er 5 mg pradofloxacin pr. kilo legemsvægt én gang daglig.
Reproduction is authorised provided the source is acknowledged. suspension it is 5 mg pradofloxacin per kilogram body weight once a day.
Reproduction is authorised provided the source is acknowledged. forskellige influenzavirusstammer.
Reproduction is authorised provided the source is acknowledged. virus.
Reproduction is authorised provided the source is acknowledged. fortsætte behandlingen med Memantine ratiopharm regelmæssigt genvurderes.
Reproduction is authorised provided the source is acknowledged. from then on the benefits of continuing treatment with Memantine ratiopharm should be re-assessed on a regular basis.
Reproduction is authorised provided the source is acknowledged. fortæres det af insekterne, hvorefter det aktiveres i deres tarme og danner et aktivt stof.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. fra blæren og til ydersiden af kroppen).
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. fremskredent nyrecellekarcinom (en form for nyrekræft), når kræften er forværret på trods af behandling med en type lægemidler kaldet VEGF-hæmmere (der blokerer virkningerne af vaskulære endoteliale vækstfaktorproteiner).
Reproduction is authorised provided the source is acknowledged. advanced renal cell carcinoma (a type of kidney cancer), when the cancer has worsened despite treatment with a ‘VEGF-targeted’ medicine (a type of medicine that blocks the effects of vascular endothelial growth factor proteins).
Reproduction is authorised provided the source is acknowledged. funktionsevne.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. gang dagligt, hvis blodets indhold af urinsyre forbliver højt (over 6 mg pr. deciliter) efter to til fire uger.
Reproduction is authorised provided the source is acknowledged. mg once a day if blood uric acid levels remain high (above 6 mg per decilitre) after two to four weeks.
Reproduction is authorised provided the source is acknowledged. gang om måneden.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. gang om ugen i fire uger og derefter én gang om måneden (vedligeholdelsesbehandling).
Reproduction is authorised provided the source is acknowledged. weekly injections followed by monthly maintenance injections.
Reproduction is authorised provided the source is acknowledged. gang ugentligt.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. gange dagligt.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. gastrisk adenocarcinom (en form for mavekræft) hos patienter, der endnu ikke har fået nogen behandling mod deres kræft.
Reproduction is authorised provided the source is acknowledged. gastric adenocarcinoma (a type of stomach cancer) in patients who have not yet received any treatment for their cancer.
Reproduction is authorised provided the source is acknowledged. glukosen til at trænge ind i cellerne fra blodet.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. hastighed, hvormed lymfocytterne formerer sig.
Reproduction is authorised provided the source is acknowledged. lymphocytes multiply.
Reproduction is authorised provided the source is acknowledged. hjerteproblemer, som omfatter hjerteanfald og ustabil angina (en svær form for brystsmerter).
Reproduction is authorised provided the source is acknowledged. include heart attacks and unstable angina (a severe type of chest pain).
Reproduction is authorised provided the source is acknowledged. holde op med at tage emtricitabin eller tenofovir eller skal have ændret dosis, skal de tage medicin indeholdende emtricitabin eller tenofovirdisoproxil hver for sig.
Reproduction is authorised provided the source is acknowledged. tenofovir, or need to take different doses, they will need to take medicines containing emtricitabine or tenofovir disoproxil separately.
Reproduction is authorised provided the source is acknowledged. holde op med at tage lamivudin eller zidovudin eller skal have en anden dosis på grund af problemer med nyrerne, leveren eller blodet, må patienten tage medicin indeholdende lamivudin eller zidovudin hver for sig.
If patients need to stop taking lamivudine or zidovudine, or need to take different doses because of problems with their kidneys, liver or blood, they will need to take medicines containing lamivudine or zidovudine separately.
Reproduction is authorised provided the source is acknowledged. hos patienter med moderat eller svært nedsat nyrefunktion eller lav legemsvægt og hos patienter, der får visse lægemidler (P-gp-hæmmere), som kan nedsætte udskillelsen af edoxaban fra kroppen.
Reproduction is authorised provided the source is acknowledged. edoxaban from the body.